Novo Nordisk or Eli Lilly? The Billion-Dollar GLP-1 Battle Is Heating Up
The global pharmaceutical industry is witnessing one of the biggest healthcare competitions in history. Two industry giants—Novo Nordisk and Eli Lilly—are …
The global pharmaceutical industry is witnessing one of the biggest healthcare competitions in history. Two industry giants—Novo Nordisk and Eli Lilly—are …
The global market for GLP-1 medicines continues to attract significant attention from patients, healthcare professionals, investors, and pharmaceutical companies. Novo Nordisk …
Every year, dozens of innovative medicines receive special FDA designations that can speed parts of the development and review process for …
The U.S. Food and Drug Administration (FDA) has approved the first gene therapy for young children with sickle cell disease, marking …
Artificial Intelligence (AI) is no longer just a buzzword in the technology sector—it has become one of the most important forces …
The pharmaceutical industry has witnessed another major acquisition as Vertex Pharmaceuticals announced an agreement to acquire Crinetics Pharmaceuticals in a transaction …
The U.S. market for GLP-1 medicines continues to expand rapidly as demand for obesity and diabetes treatments grows. In another important …
The U.S. Food and Drug Administration (FDA) has approved a wearable injector version of Sanofi’s blood cancer medicine Sarclisa for eligible …
The U.S. Food and Drug Administration (FDA) has proposed a new rule that could simplify registration requirements for certain drug manufacturers …
Every year, thousands of pharmacy and science graduates attend interviews hoping to secure their first job. Many candidates have good academic …